# OnCo record paper-acns0331-michalski-jco-2021 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-acns0331-michalski-jco-2021/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-acns0331-michalski-jco-2021" ;
  schema:name "ACNS0331: reduced-dose and reduced-volume radiotherapy with chemotherapy for average-risk medulloblastoma"@en ;
  schema:description "Reducing the radiotherapy boost to the tumour bed instead of the whole posterior fossa was safe in average-risk medulloblastoma, but lowering the craniospinal dose from 23.4 to 18 Gy in young children led to more relapses, so the standard dose was kept."@en ;
  schema:url <https://onco.cc/key-papers/paper-acns0331-michalski-jco-2021/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://doi.org/10.1200/JCO.20.02730>, <https://pubmed.ncbi.nlm.nih.gov/34110925/> ;
  schema:sameAs <https://doi.org/10.1200/JCO.20.02730> ;
  schema:datePublished "2021"^^xsd:gYear ;
  schema:author "Michalski JM, Janss AJ, Vezina LG, et al." ;
  onco:cancers <https://onco.cc/cancers/medulloblastoma-group-3-4/>, <https://onco.cc/cancers/medulloblastoma-wnt/> ;
  onco:trials <https://onco.cc/trials/acns0331/> ;
  onco:journals <https://onco.cc/journals/jco/> .